{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:03:16Z","timestamp":1791540196348,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","award":["Corre contra el c\u00e1ncer"],"award-info":[{"award-number":["Corre contra el c\u00e1ncer"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","award":["Consulado de Canada en Sinaloa."],"award-info":[{"award-number":["Consulado de Canada en Sinaloa."]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GANAC-IAP","award":["2010"],"award-info":[{"award-number":["2010"]}]},{"name":"PROFAPI-UAS","award":["2022-A3-037"],"award-info":[{"award-number":["2022-A3-037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10534-022-00484-4","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T11:04:10Z","timestamp":1673348650000},"page":"639-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Izamar G.","family":"Arredondo-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"Ram\u00edrez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas R.","family":"Zazueta-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Canizalez-Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uriel A.","family":"Angulo-Zamudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Velazquez-Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G. M.","family":"Bolscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Nazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-3383","authenticated-orcid":false,"given":"Nidia","family":"Le\u00f3n-Sicairos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"22","key":"484_CR1","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s00018-005-5368-9","volume":"62","author":"EN Baker","year":"2005","unstructured":"Baker EN, Baker HM (2005a) Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 62(22):2531\u20132539","journal-title":"Cell Mol Life Sci"},{"issue":"22","key":"484_CR2","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s00018-005-5368-9","volume":"62","author":"EN Baker","year":"2005","unstructured":"Baker EN, Baker HM (2005b) Lactoferrin. Cell Mol Life Sci 62(22):2531","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"484_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/cdd.2009.184","volume":"17","author":"TV Berghe","year":"2010","unstructured":"Berghe TV et al (2010) Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 17(6):922\u2013930","journal-title":"Cell Death Differ"},{"issue":"1","key":"484_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biochi.2008.05.019","volume":"91","author":"JG Bolscher","year":"2009","unstructured":"Bolscher JG et al (2009) Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie 91(1):123\u2013132","journal-title":"Biochimie"},{"issue":"4","key":"484_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150(4):835\u2013853","journal-title":"Gastroenterology"},{"key":"484_CR6","unstructured":"Cancer, I.A.f.R.o. Estimated number of deaths worldwide, both sexes, all ages (excl. NMSC). 2020 [cited 2022; Available from: https:\/\/gco.iarc.fr\/today\/home."},{"issue":"1","key":"484_CR7","doi-asserted-by":"publisher","first-page":"e0191683","DOI":"10.1371\/journal.pone.0191683","volume":"13","author":"C Chea","year":"2018","unstructured":"Chea C et al (2018) Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma. PLoS ONE 13(1):e0191683\u2013e0191683","journal-title":"PLoS ONE"},{"issue":"2","key":"484_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Can Res 70(2):440","journal-title":"Can Res"},{"issue":"5","key":"484_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10534-014-9742-7","volume":"27","author":"A Cutone","year":"2014","unstructured":"Cutone A et al (2014) Lactoferrin prevents LPS-induced decrease of the iron exporter ferroportin in human monocytes\/macrophages. Biometals 27(5):807\u2013813","journal-title":"Biometals"},{"issue":"5","key":"484_CR10","first-page":"2703","volume":"22","author":"LT Eliassen","year":"2002","unstructured":"Eliassen LT et al (2002) Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 22(5):2703\u20132710","journal-title":"Anticancer Res"},{"issue":"1","key":"484_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tiv.2009.08.021","volume":"24","author":"E Farkas","year":"2010","unstructured":"Farkas E et al (2010) Apoptogenic and necrogenic effects of mercuric acetate on the chromatin structure of K562 human erythroleukemia cells. Toxicol in Vitro 24(1):267\u2013275","journal-title":"Toxicol in Vitro"},{"issue":"10","key":"484_CR12","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/carcin\/bgh205","volume":"25","author":"K Fujita","year":"2004","unstructured":"Fujita K et al (2004) Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25(10):1961\u20131966","journal-title":"Carcinogenesis"},{"key":"484_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12885-015-1441-4","volume":"15","author":"JA Gibbons","year":"2015","unstructured":"Gibbons JA, Kanwar JR, Kanwar RK (2015) Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15:425\u2013425","journal-title":"BMC Cancer"},{"key":"484_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fonc.2018.00200","volume":"8","author":"JP Guedes","year":"2018","unstructured":"Guedes JP et al (2018) Bovine milk lactoferrin selectively kills highly metastatic prostate cancer PC-3 and osteosarcoma MG-63 cells in vitro. Front Oncol 8:200\u2013200","journal-title":"Front Oncol"},{"issue":"2","key":"484_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.beha.2019.05.008","volume":"32","author":"VA Guerra","year":"2019","unstructured":"Guerra VA, DiNardo C, Konopleva M (2019) Venetoclax-based therapies for acute myeloid leukemia. Best Pract Res Clin Haematol 32(2):145\u2013153","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1\u20132","key":"484_CR16","first-page":"27","volume":"5","author":"S Igder","year":"2013","unstructured":"Igder S et al (2013) Opium induces apoptosis in jurkat cells. Addict Health 5(1\u20132):27\u201334","journal-title":"Addict Health"},{"key":"484_CR17","doi-asserted-by":"publisher","unstructured":"Juliusson G, Hough R (2016) Leukemia. Prog Tumor Res 43:87\u2013100. https:\/\/doi.org\/10.1159\/000447076","DOI":"10.1159\/000447076"},{"issue":"1","key":"484_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ped.13457","volume":"60","author":"M Kato","year":"2018","unstructured":"Kato M, Manabe A (2018) Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int 60(1):4\u201312","journal-title":"Pediatr Int"},{"issue":"48","key":"484_CR19","doi-asserted-by":"publisher","first-page":"10464","DOI":"10.1021\/acs.jafc.7b03390","volume":"65","author":"H-Y Li","year":"2017","unstructured":"Li H-Y et al (2017) Lactoferrin exerts antitumor effects by inhibiting angiogenesis in a HT29 human colon tumor model. J Agric Food Chem 65(48):10464\u201310472","journal-title":"J Agric Food Chem"},{"key":"484_CR20","doi-asserted-by":"publisher","first-page":"20823","DOI":"10.1038\/srep20823","volume":"6","author":"Y Lu","year":"2016","unstructured":"Lu Y et al (2016) PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells. Sci Rep 6:20823\u201320823","journal-title":"Sci Rep"},{"issue":"1","key":"484_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cbf.3242","volume":"35","author":"C Luzi","year":"2017","unstructured":"Luzi C et al (2017) Apoptotic effects of bovine apo-lactoferrin on hela tumor cells. Cell Biochem Funct 35(1):33\u201341","journal-title":"Cell Biochem Funct"},{"key":"484_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.fct.2013.05.038","volume":"59","author":"J Ma","year":"2013","unstructured":"Ma J et al (2013) Comparison of anticancer activity between lactoferrin nanoliposome and lactoferrin in Caco-2 cells in vitro. Food Chem Toxicol 59:72\u201377","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"484_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/1535-7163.MCT-04-0077","volume":"4","author":"JS Mader","year":"2005","unstructured":"Mader JS et al (2005) Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 4(4):612\u2013624","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"484_CR24","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/molecules14061999","volume":"14","author":"I Massodi","year":"2009","unstructured":"Massodi I, Thomas E, Raucher D (2009) Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 14(6):1999\u20132015","journal-title":"Molecules"},{"issue":"1","key":"484_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3892\/ol.2016.5415","volume":"13","author":"L Meng","year":"2017","unstructured":"Meng L et al (2017) Bovine lactoferricin P13 triggers ROS-mediated caspase-dependent apoptosis in SMMC7721 cells. Oncol Lett 13(1):511\u2013517","journal-title":"Oncol Lett"},{"key":"484_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/184278","author":"TM Moastafa","year":"2014","unstructured":"Moastafa TM et al (2014) Study on the therapeutic benefit on lactoferrin in patients with colorectal cancer receiving chemotherapy. Int Sch Res Notices. https:\/\/doi.org\/10.1155\/2014\/184278","journal-title":"Int Sch Res Notices"},{"issue":"9","key":"484_CR27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/psc.1039","volume":"14","author":"J Onishi","year":"2008","unstructured":"Onishi J et al (2008) A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60). J Pept Sci 14(9):1032\u20131038","journal-title":"J Pept Sci"},{"issue":"38","key":"484_CR28","doi-asserted-by":"publisher","first-page":"62144","DOI":"10.18632\/oncotarget.11394","volume":"7","author":"CS Pereira","year":"2016","unstructured":"Pereira CS et al (2016) Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase. Oncotarget 7(38):62144\u201362158","journal-title":"Oncotarget"},{"key":"484_CR29","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2020-0074","author":"DA Ramirez-Sanchez","year":"2020","unstructured":"Ramirez-Sanchez DA et al (2020) Bovine lactoferrin and lactoferrin peptides affect endometrial and cervical cancer cell lines. Biochem Cell Biol. https:\/\/doi.org\/10.1139\/bcb-2020-0074","journal-title":"Biochem Cell Biol"},{"issue":"9","key":"484_CR30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3168\/jds.S0022-0302(02)74284-7","volume":"85","author":"MK Roy","year":"2002","unstructured":"Roy MK et al (2002) Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells. J Dairy Sci 85(9):2065\u20132074","journal-title":"J Dairy Sci"},{"issue":"3","key":"484_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4103\/0019-509X.200658","volume":"53","author":"PS Roy","year":"2016","unstructured":"Roy PS, Saikia BJ (2016) Cancer and cure: a critical analysis. Indian J Cancer 53(3):441\u2013442","journal-title":"Indian J Cancer"},{"issue":"9","key":"484_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","volume":"82","author":"R Seth","year":"2015","unstructured":"Seth R, Singh A (2015) Leukemias in children. Indian J Pediatr 82(9):817\u2013824","journal-title":"Indian J Pediatr"},{"issue":"5","key":"484_CR33","first-page":"5688","volume":"14","author":"Y Sugihara","year":"2017","unstructured":"Sugihara Y et al (2017) Inhibition of DMH-DSS-induced colorectal cancer by liposomal bovine lactoferrin in rats. Oncol Lett 14(5):5688\u20135694","journal-title":"Oncol Lett"},{"issue":"1","key":"484_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/excr.1999.4500","volume":"250","author":"P Valenti","year":"1999","unstructured":"Valenti P et al (1999) Apoptosis of Caco-2 intestinal cells invaded by Listeria monocytogenes: protective effect of lactoferrin. Exp Cell Res 250(1):197\u2013202","journal-title":"Exp Cell Res"},{"issue":"3","key":"484_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1139\/o2012-016","volume":"90","author":"HJ Vogel","year":"2012","unstructured":"Vogel HJ (2012) Lactoferrin, a bird\u2019s eye view. Biochem Cell Biol 90(3):233\u2013244","journal-title":"Biochem Cell Biol"},{"issue":"7\u201312","key":"484_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1699-0463.1999.tb01499.x","volume":"107","author":"LH Vorland","year":"1999","unstructured":"Vorland LH (1999) Lactoferrin: a multifunctional glycoprotein. APMIS 107(7\u201312):971\u2013981","journal-title":"APMIS"},{"key":"484_CR37","first-page":"5123","volume":"10","author":"M Wei","year":"2015","unstructured":"Wei M et al (2015) Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma. Int J Nanomed 10:5123\u20135137","journal-title":"Int J Nanomed"},{"issue":"5","key":"484_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000075220","volume":"65","author":"JS Wolf","year":"2003","unstructured":"Wolf JS et al (2003) Lactoferrin inhibits growth of malignant tumors of the head and neck. ORL 65(5):245\u2013249","journal-title":"ORL"},{"issue":"5","key":"484_CR39","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1158\/1078-0432.CCR-06-2008","volume":"13","author":"JS Wolf","year":"2007","unstructured":"Wolf JS et al (2007) Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer 13(5):1601\u20131610","journal-title":"Clin Cancer"},{"issue":"24","key":"484_CR40","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1158\/1078-0432.CCR-04-0988","volume":"10","author":"Y Xiao","year":"2004","unstructured":"Xiao Y et al (2004) Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res 10(24):8683","journal-title":"Clin Cancer Res"},{"key":"484_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.idairyj.2014.08.016","volume":"40","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Lima CF, Rodrigues LR (2015) In vitro evaluation of bovine lactoferrin potential as an anticancer agent. Int Dairy J 40:6\u201315","journal-title":"Int Dairy J"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00484-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-022-00484-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00484-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:28:54Z","timestamp":1683887334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-022-00484-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s10534-022-00484-4","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}